-
Symbol
-
LYEL on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001
-
Latest Disclosed Shares Owned
-
1,900,000 shares
-
Security Ownership %
-
9.8%
Innovative Cellular Therapeutics Holdings Ltd ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)
13 Nov 2025 - Innovative Cellular Therapeutics Holdings Ltd has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,900,000 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).
This represents 9.8% ownership of the company.
This is the first filing by Innovative Cellular Therapeutics Holdings Ltd disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).